Table 3. Diagnostic strategy and management of sarcopenia of healthcare professionals five months after attendance (n = 80).
| Total n = 80 | |
|---|---|
| Diagnostic strategy | |
| Implementation of diagnostic strategy | 43 (53.8) |
| Application of diagnostic strategy | |
| All older adultsa | 12 (15.4) |
| Older adults with comorbiditya | 18 (23.1) |
| Older adults with mobility problemsa | 29 (37.2) |
| Older adults with malnutritiona | 22 (28.2) |
| Screening percentage, median [IQR]b | 0 [0–4.5] |
| Diagnostic measuresc | |
| No measures | 56 (70.9) |
| Muscle mass | 11 (13.9) |
| Handgrip strength | 40 (50.6) |
| Gait speed | 43 (54.4) |
| Experienced bottlenecksb | 49 (67.1) |
| Lack of awareness among other healthcare professionals | 23 (31.9) |
| Not convinced or motivated about sarcopenia | 5 (6.9) |
| Acquisition of a device to measure muscle mass | 22 (30.6) |
| Acquisition of handgrip strength device | 8 (11.1) |
| No space for walking test to assess gait speed | 3 (4.2) |
| Time constrains to perform the diagnostic tests | 22 (30.6) |
| No funding source specific for sarcopenia | 9 (12.5) |
| Management–Collaborationd | |
| Lack of collaboration | 25 (36.8) |
All variables are presented as n (%) unless indicated otherwise.
IQR interquartile range. Data available in a subgroup of an = 78, bn = 72, cn = 79, dn = 68